Factors contributing to the low completion rate of the HPV vaccine series and potential strategies to increase uptake among adolescents in the United States

Rodkey, Johanna (2014) Factors contributing to the low completion rate of the HPV vaccine series and potential strategies to increase uptake among adolescents in the United States. Master Essay, University of Pittsburgh.

	Microsoft Word Submitted Version Available under License : See the attached license file. Download (531kB)
	Plain Text (licence) Available under License : See the attached license file. Download (1kB)

Abstract

The human papillomavirus (HPV) is a very common sexually transmitted infection that affects an estimated 14 million people each year in the United States. There are two licensed prophylactic HPV vaccines currently available for use: a quadrivalent vaccine that protects against HPV types 6, 11, 16, and 18 and a bivalent vaccine that protects against HPV types 16 and 18. Less than half of American adolescents are getting vaccinated against HPV, which is responsible for close to 26,000 incidence cases of cancer in men and women every year in the United States. Cancer prevention through vaccination is a significant public health achievement, although the benefit is only realized with uptake of the vaccine. Challenges including cost and delivery of the vaccine are prevalent, but the social challenges, including the misconceptions regarding safety and efficacy, perception of risk, and consequences of vaccination, are among the most difficult to overcome. However, a strong collaborative effort among health care providers, public health professionals, and legislators has the potential to overcome these challenges, increase uptake of the HPV vaccine, and ultimately prevent future cancers. An analysis of several HPV vaccination mandate scenarios indicate that 4,190 estimated cases of cervical cancer could be prevented by increasing vaccine coverage to 80% among girls entering public school for 6th grade (11-12 years old) in 2015. In addition to the decrease in estimated HPV-associated disease outcomes, health care costs decrease with a greater proportion of the population vaccinated. Compared to the current vaccination rate, vaccinating 90% of the population has the potential to save 219 million 2015 U.S.$ in health care costs associated with oropharyngeal cancer and 212 million 2015 U.S.$ in health case costs associated with cervical cancer. Information regarding the health and economic burden of HPV-associated disease may be useful to policymakers and public health professionals for informed decisions about investments in future HPV prevention programs.

---

Share

Citation/Export:	Select format... Citation - Text Citation - HTML Endnote BibTex Dublin Core OpenURL MARC (ISO 2709) METS MODS EP3 XML Reference Manager Refer
Social Networking:	Share |

---

Details

Item Type:	Other Thesis, Dissertation, or Long Paper (Master Essay)
Status:	Unpublished
Creators/Authors:	Creators Email Pitt Username ORCID Rodkey, Johanna
Contributors:	Contribution Contributors Name Email Pitt Username ORCID Committee Chair Ayyavoo, Velpandi velpandi@pitt.edu VELPANDI UNSPECIFIED Committee Member Mertz, Kristen J. kjm40@pitt.edu KJM40 UNSPECIFIED
Date:	22 April 2014
Date Type:	Publication
Defense Date:	2014
Submission Date:	7 April 2014
Access Restriction:	No restriction; Release the ETD for access worldwide immediately.
Publisher:	University of Pittsburgh
Institution:	University of Pittsburgh
Schools and Programs:	School of Public Health > Infectious Diseases and Microbiology
Degree:	MPH - Master of Public Health
Thesis Type:	Master Essay
Refereed:	Yes
Uncontrolled Keywords:	HPV, Human, Papillomavirus, Vaccine, STD, Cervical, cancer, Genital, warts
Date Deposited:	22 May 2015 21:31
Last Modified:	30 Mar 2022 12:00
URI:	http://d-scholarship.pitt.edu/id/eprint/21502

Available Versions of this Item

• Factors contributing to the low completion rate of the HPV vaccine series and potential strategies to increase uptake among adolescents in the United States. (deposited 22 May 2015 21:31) [Currently Displayed]

---

Metrics

Monthly Views for the past 3 years

Plum Analytics

---

Actions (login required)

View Item